-
Wegovy pill could increase access to obesity treatment
BY MELISSA PATRICK KENTUCKY HEALTH NEWS The U.S. Food and Drug Administration has approved the first pill version of a GLP-1 drug for weight loss, a move that could significantly widen access to the treatment for obesity. The once-daily Wegovy pill, made by Danish company Novo Nordisk, is expected to launch in early January. Novo
-
Whipsawed by the system, dozens of independent pharmacies closed in Kentucky last year, and more are expected to follow suit
KENTUCKY HEALTH NEWS In the past year, at least 67 independent pharmacies have closed in Kentucky, and more are expected to close because of a recent change in the system that favors big pharmacy chains. So reports Alex Acquisto of the Lexington Herald-Leader in a significant story for rural Kentucky. “Pharmacists are often the first
